US HB6958 | 2017-2018 | 115th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on September 27 2018 - 25% progression, died in committee
Action: 2018-09-27 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on September 27 2018 - 25% progression, died in committee
Action: 2018-09-27 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Drug Price Transparency Act This bill requires the Centers for Medicare & Medicaid Services to report on the feasibility of basing payment rates for prescription drugs under Medicare and Medicare Advantage on the average price of such drugs in countries that are members of the Organization for Economic Cooperation and Development (an intergovernmental organization focused on global economic development).
Title
Drug Price Transparency Act
Sponsors
Rep. Francis Rooney [R-FL] | Sen. Peter Welch [D-VT] |
History
Date | Chamber | Action |
---|---|---|
2018-09-27 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2018-09-27 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2018-09-27 | House | Introduced in House |
Subjects
Congressional oversight
Government studies and investigations
Health
Health care costs and insurance
Inflation and prices
International organizations and cooperation
Medicare
Prescription drugs
Government studies and investigations
Health
Health care costs and insurance
Inflation and prices
International organizations and cooperation
Medicare
Prescription drugs
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/115th-congress/house-bill/6958/all-info |
Text | https://www.congress.gov/115/bills/hr6958/BILLS-115hr6958ih.pdf |